Details of the Drug | DrugMAP

General Information of Drug (ID: DMFVQOW)

Drug Name

PM-060184

Indication

Disease Entry	ICD 11	Status	REF
Solid tumour/cancer	2A00-2F9Z	Phase 1	[1]
------------------------------------------------------------------------------------

Structure

3D MOL is unavailable

2D MOL

Chemical Identifiers

Formula: C31H45N3O7
Canonical SMILES: CC=CCC(CC=CNC(=O)C(C(C)(C)C)NC(=O)C=CC=CC(=CC(C)C1CC=C(C(=O)O1)OC)C)OC(=O)N
InChI: 1S/C31H45N3O7/c1-8-9-14-23(40-30(32)38)15-12-19-33-28(36)27(31(4,5)6)34-26(35)16-11-10-13-21(2)20-22(3)24-17-18-25(39-7)29(37)41-24/h8-13,16,18-20,22-24,27H,14-15,17H2,1-7H3,(H2,32,38)(H,33,36)(H,34,35)/b9-8-,13-10-,16-11-,19-12-,21-20+/t22-,23-,24-,27+/m0/s1
InChIKey: IEKGSKLKBICCHQ-BDOJOPHNSA-N

Cross-matching ID

PubChem CID: 57788271
CAS Number: 960210-99-5
TTD ID: D0W5YY

References

1	ClinicalTrials.gov (NCT01299636) Study of PM060184 in Patients With Advanced Solid Tumors. U.S. National Institutes of Health.